Fulcrum Therapeutics, Inc.

Organization

LOS ANGELES, CA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods for modulating FMR1 expression
- Patent number 11,819,554
- Issue date Nov 21, 2023
- University of Massachusetts
- Michael R. Green
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
- Patent number 11,590,111
- Issue date Feb 28, 2023
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich Efremov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of p38 inhibitors to reduce expression of DUX4
- Patent number 11,479,770
- Issue date Oct 25, 2022
- Fulcrum Therapeutics, Inc.
- Angela Marie Cacace
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...
- Patent number 11,291,659
- Issue date Apr 5, 2022
- Fulcrum Therapeutics, Inc.
- Angela Marie Cacace
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
- Patent number 10,973,805
- Issue date Apr 13, 2021
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich Efremov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...
- Patent number 10,537,560
- Issue date Jan 21, 2020
- Fulcrum Therapeutics. Inc.
- Angela Marie Cacace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...
- Patent number 10,342,786
- Issue date Jul 9, 2019
- Fulcrum Therapeutics, Inc.
- Angela Marie Cacace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF REGULATING BCL11A EXPRESSION AND TREATMENT OF BCL11A-MED...
- Publication number 20240238296
- Publication date Jul 18, 2024
- Fulcrum Therapeutics, Inc.
- Paul Bruno
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
POLYMORPHIC FORMS OF (S)-12-FLUORO-4-(1-METHYL-1H-PYRAZOL-5-YL)-7A,...
- Publication number 20240199645
- Publication date Jun 20, 2024
- Fulcrum Therapeutics, Inc.
- Steven M. Mennen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
- Publication number 20240139163
- Publication date May 2, 2024
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich EFREMOV
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4
- Publication number 20230257743
- Publication date Aug 17, 2023
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20220282254
- Publication date Sep 8, 2022
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
- Publication number 20220160686
- Publication date May 26, 2022
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich EFREMOV
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20220133704
- Publication date May 5, 2022
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR INCREASING FETAL HEMOGLOBIN AND TREATI...
- Publication number 20220017908
- Publication date Jan 20, 2022
- Fulcrum Therapeutics, Inc.
- Peter Rahl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20200383963
- Publication date Dec 10, 2020
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS
- Publication number 20200360353
- Publication date Nov 19, 2020
- Fulcrum Therapeutics, Inc.
- Ivan Viktorovich EFREMOV
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4
- Publication number 20200332291
- Publication date Oct 22, 2020
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20190105311
- Publication date Apr 11, 2019
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...
- Publication number 20190105312
- Publication date Apr 11, 2019
- Fulcrum Therapeutics, Inc.
- Angela Marie CACACE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR MODULATING FMR1 EXPRESSION
- Publication number 20180256749
- Publication date Sep 13, 2018
- University of Massachusetts
- Michael R. Green
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98437137 - MEVMYNTO
- Serial number 98437137
- Filing date Mar 6, 2024
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98437143 - SEFIDENCE
- Serial number 98437143
- Filing date Mar 6, 2024
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98437140 - REMPLYA
- Serial number 98437140
- Filing date Mar 6, 2024
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98437152 - EMROVLY
- Serial number 98437152
- Filing date Mar 6, 2024
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97629045 - EMRUKYO
- Serial number 97629045
- Filing date Oct 12, 2022
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97388495 - FYSMOVY
- Serial number 97388495
- Filing date Apr 29, 2022
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97388480 - OHMOVY
- Serial number 97388480
- Filing date Apr 29, 2022
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97388474 - OMMOVY
- Serial number 97388474
- Filing date Apr 29, 2022
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97388509 - FAZMYO
- Serial number 97388509
- Filing date Apr 29, 2022
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97388503 - FYSMOVDY
- Serial number 97388503
- Filing date Apr 29, 2022
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97359714 - REACH
- Serial number 97359714
- Filing date Apr 12, 2022
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97304026 - RISE
- Serial number 97304026
- Filing date Mar 9, 2022
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97292298 - REACH
- Serial number 97292298
- Filing date Mar 2, 2022
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97292306 - FSHD REACH
- Serial number 97292306
- Filing date Mar 2, 2022
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
97264241 - THE HBF PILL
- Serial number 97264241
- Registration number 7050850
- Filing date Feb 11, 2022
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88981629
- Serial number 88981629
- Registration number 6412753
- Filing date Sep 20, 2019
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88625061
- Serial number 88625061
- Filing date Sep 20, 2019
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88430181 - FULCRUM
- Serial number 88430181
- Registration number 7012695
- Filing date May 14, 2019
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88430224 - FULCRUMSEQ
- Serial number 88430224
- Filing date May 14, 2019
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88981580 - FULCRUM
- Serial number 88981580
- Registration number 6398116
- Filing date May 14, 2019
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88430197 - FULCRUMSEEK
- Serial number 88430197
- Registration number 6747166
- Filing date May 14, 2019
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
88430193 - FULCRUM THERAPEUTICS
- Serial number 88430193
- Registration number 6991940
- Filing date May 14, 2019
- Fulcrum Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88981581 - FULCRUM THERAPEUTICS
- Serial number 88981581
- Registration number 6398117
- Filing date May 14, 2019
- Fulcrum Therapeutics, Inc.
- 42 - Scientific and technological services and research and design relating thereto

Fulcrum Therapeutics, Inc.

Organization

Patents Grantslast 30 patents

Compositions and methods for modulating FMR1 expression

Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

Use of p38 inhibitors to reduce expression of DUX4

P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...

Macrocyclic azolopyridine derivatives as EED and PRC2 modulators

P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...

P38 kinase inhibitors reduce DUX4 and downstream gene expression fo...

Patents Applicationslast 30 patents

METHODS OF REGULATING BCL11A EXPRESSION AND TREATMENT OF BCL11A-MED...

POLYMORPHIC FORMS OF (S)-12-FLUORO-4-(1-METHYL-1H-PYRAZOL-5-YL)-7A,...

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

COMPOSITIONS AND METHODS FOR INCREASING FETAL HEMOGLOBIN AND TREATI...

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

MACROCYCLIC AZOLOPYRIDINE DERIVATIVES AS EED AND PRC2 MODULATORS

USE OF P38 INHIBITORS TO REDUCE EXPRESSION OF DUX4

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

P38 KINASE INHIBITORS REDUCE DUX4 AND DOWNSTREAM GENE EXPRESSION FO...

COMPOSITIONS AND METHODS FOR MODULATING FMR1 EXPRESSION

Trademarklast 30 trademarks

98437137 - MEVMYNTO

98437143 - SEFIDENCE

98437140 - REMPLYA

98437152 - EMROVLY

97629045 - EMRUKYO

97388495 - FYSMOVY

97388480 - OHMOVY

97388474 - OMMOVY

97388509 - FAZMYO

97388503 - FYSMOVDY

97359714 - REACH

97304026 - RISE

97292298 - REACH

97292306 - FSHD REACH

97264241 - THE HBF PILL

88981629

88625061

88430181 - FULCRUM

88430224 - FULCRUMSEQ

88981580 - FULCRUM

88430197 - FULCRUMSEEK

88430193 - FULCRUM THERAPEUTICS

88981581 - FULCRUM THERAPEUTICS